Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/4/2019
FDA approves Sanofi’s Fluzone High Dose Quadrivalent
Sanofi’s Fluzone High-Dose Quadrivalent is used in people age 65 and older, to protect against influenza A and B strains. - 11/3/2019
Endo implements CEO succession plan
Paul Campanelli has been named Endo chairman of the board, and will continue as president and CEO until a successor is appointed. - 11/3/2019
Camber gets FDA nod for generic Bentyl
Generic Bentyl is Camber's first injectable product to hit the market. - 11/3/2019
FDA approves third indication for Lupin’s generic Levoxyl
Lupin's levothyroxine sodium tablets now is approved as a generic of Synthroid, Unithroid, and Levoxyl. - 10/31/2019
Hy-Vee, customers to honor veterans, active-duty military members, and families
Hy-Vee will match customer donations up to $100,000, during its seventh annual Hy-Vee Homefront Round Up this month. - 10/31/2019
President Trump to nominate oncologist Stephen Hahn as FDA commissioner
President Trump will nominate Stephen Hahn, chief medical executive at The University of Texas MD Anderson Cancer Center, as FDA commissioner. - 10/30/2019
Hy-Vee to provide free A1C screenings in November
Free hemoglobin A1C screenings will be offered on a first-come, first-served basis at the Hy-Vee Healthy You Mobiles in 160 Hy-Vee store parking lots. - 10/30/2019
AmerisourceBergen’s ThinkLive Summit focuses on innovation and patient access
AmerisourceBergen's ThinkLive Summit showcased innovation and patient access, survey results, and awards. - 10/30/2019
NACDS restructures, shifts staff roles to empower its issue campaigns
NACDS' federal government affairs, state government affairs, and public policy now will operate as dedicated and distinct, yet highly collaborative, functions. - 10/30/2019
SunGen gets FDA nod for lidocaine ointment
Lidocaine has a market value of about $60 million.
